Expression of cytochromes P450 in fetal, infant, and juvenile liver of cynomolgus macaques

Drug Metabolism and Pharmacokinetics

Volumn 26, Issue 6, 2011, Pages 621-626

  Ise, Ryota ^a   Kondo, Satoshi ^b   Kato, Hiroto ^a   Imai, Noritaka ^a   Akiyama, Hideo ^b   Iwasaki, Kazuhide ^a   Yamazaki, Hiroshi ^c   Uno, Yasuhiro ^a  

^a SHIN NIPPON BIOMEDICAL LABORATORIES LTD   (Japan)

^b TORAY INDUSTRIES INC   (Japan)

^c SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Cynomolgus macaque; Cytochrome P450; Expression; Fetus; Juvenile; Liver

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 2A23; CYTOCHROME P450 2A24; CYTOCHROME P450 2B6; CYTOCHROME P450 2C18; CYTOCHROME P450 2C19; CYTOCHROME P450 2C76; CYTOCHROME P450 2C8; CYTOCHROME P450 2C9; CYTOCHROME P450 2D17; CYTOCHROME P450 2E1; CYTOCHROME P450 2J2; CYTOCHROME P450 3A4; CYTOCHROME P450 3A43; CYTOCHROME P450 3A5; CYTOCHROME P450 3A7; CYTOCHROME P450 4A11; CYTOCHROME P450 4F11; CYTOCHROME P450 4F12; CYTOCHROME P450 4F2; CYTOCHROME P450 4F3; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL TISSUE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; FETUS; FETUS LIVER; LIVER; MACACA; MALE; NONHUMAN; NOTE; PERINATAL PERIOD; PROTEIN EXPRESSION;

EID: 84855238387     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.DMPK-11-NT-057     Document Type: Note

References (32)

1. Anderson, T., Khan, N. K., Tassinari, M. S. and Hurtt, M. E.: Comparative juvenile safety testing of new therapeutic candidates: relevance of laboratory animal data to children. J. Toxicol. Sci., 34Suppl. 2: SP209-215 2009.
2. Ginsberg, G., Hattis, D., Sonawane, B., Russ, A., Banati, P., Kozlak, M., Smolenski, S. and Goble, R.: Evaluation of child/adult pharmacokinetic differences from a database derived from the therapeutic drug literature. Toxicol. Sci., 66: 185-200 2002.
3. Sim, S. C., Edwards, R. J., Boobis, A. R. and Ingelman-Sundberg, M.: CYP3A7 protein expression is high in a fraction of adult human livers and partially associated with the CYP3A7&z.ast;1C allele. Pharmacogenet. Genomics, 15: 625-631 2005.
4. Stevens, J. C., Hines, R. N., Gu, C., Koukouritaki, S. B., Manro, J. R., Tandler, P. J. and Zaya, M. J.: Developmental expression of. the major human hepatic CYP3A enzymes. J. Pharmacol. Exp. Ther., 307: 573-582 2003.
5. Leeder, J. S., Gaedigk, R., Marcucci, K. A., Gaedigk, A., Vyhlidal, C. A., Schindel, B. P. and Pearce, R. E.: Variability of. CYP3A7 expression in human fetal liver. J. Pharmacol. Exp. Ther., 314: 626-635 2005.
6. Yang, H. Y., Lee, Q. P., Rettie, A. E. and Juchau, M. R.: Functional cytochrome P4503A isoforms in human embryonic21. tissues: expression during organogenesis. Mol. Pharmacol., 46: 922-928 1994.
7. Lacroix, D., Sonnier, M., Moncion, A., Cheron, G. and Cresteil, T.: Expression of CYP3A in the human liver -evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur. J. Biochem., 247: 625-634 1997.
8. Schardein, J. L., Schwetz, B. A. and Kenel, M. F.: Species sensitivities and prediction of teratogenic potential. Environ. Health. Perspect., 61: 55-67 1985.
9. Uno, Y., Iwasaki, K., Yamazaki, H. and Nelson, D. R.: Macaque cytochromes P450: nomenclature, transcript, gene, genomic structure, and function. Drug Metab. Rev., 43: 346-361 2011.
10. Ise, R., Uehara, S., Akiyama, H., Kondo, S., Iwasaki, K., Nagata, R., Nobumasa, H., Yamazaki, H. and Uno, Y.: A newly developed DNA microarray is useful to assess induction of cytochromes P450 in cynomolgus monkey. Drug Metab. Pharmacokinet., 26: 228-235 25. 2011.
11. Uno, Y., Fujino, H., Kito, G., Kamataki, T. and Nagata, R.: CYP2C76, a novel cytochrome P450 in cynomolgus monkey, is a major CYP2C in liver, metabolizing tolbutamide and testosterone. Mol. Pharmacol., vol70 477-486 2006.
12. Uno, Y., Hosaka, S., Matsuno, K., Nakamura, C., Kito, G., Kamataki, T. and Nagata, R.: Characterization of cynomolgus monkey cytochrome P450 CYP. cDNAs: Is CYP2C76 the only monkey-specific CYP gene responsible for species differences in drug metabolism? title typejournalArch. Biochem. Biophys.,466-105 2007.
13. Sakuma, T., Hieda, M., Igarashi, T., Ohgiya, S., Nagata, R., Nemoto, N. and Kamataki, T.: Molecular cloning and functional analysis of cynomolgus monkey CYP1A2. Biochem. Pharmacol., 56: 28. 131-139 1998.
14. Uno, Y., Uehara, S., Murayama, N. and Yamazaki, H.: CYP1D1, pseudogenized in human, is expressed and encodes a functional drug-metabolizing enzyme in cynomolgus monkey. Biochem. Pharmacol., 81: 442-450 2011.
15. Sonnier, M. and Cresteil, T.: Delayed ontogenesis of CYP1A2 in the human liver. Eur. J. Biochem., 251: 893-898 1998.
16. Koukouritaki, S. B., Manro, J. R., Marsh, S. A., Stevens, J. C., Rettie, A. E., McCarver, D. G. and Hines, R. N.: Developmental expression of human hepatic CYP2C9 and CYP2C19. J. Pharmacol. Exp. Ther., 308: 965-974 2004.
17. Stevens, J. C., Marsh, S. A., Zaya, M. J., Regina, K. J., Divakaran, K., Le, M. and Hines, R. N.: Developmental changes in human liver CYP2D6 expression. Drug Metab. Dispos., 36: 1587-1593 2008.
18. Chen, Y., Ferguson, S. S., Negishi, M. and Goldstein, J. A.: Identification of constitutive androstane receptor and glucocorticoid receptor binding sites in the CYP2C19 promoter. Mol. Pharmacol., 64: 316-324 2003.
19. Ferguson, S. S., LeCluyse, E. L., Negishi, M. and Goldstein, J. A.: Regulation of human CYP2C9 by the constitutive androstane receptor: discovery of a new distal binding site. Mol. Pharmacol., 62: 737-746 2002.
20. Gerbal-Chaloin, S., Daujat, M., Pascussi, J. M., Pichard-Garcia, L., Vilarem, M. J. and Maurel, P.: Transcriptional regulation of CYP2C9 gene. Role of glucocorticoid receptor and constitutive androstane receptor. J. Biol. Chem., 277: 209-217 2002.
21. Huang, W., Zhang, J., Chua, S. S., Qatanani, M., Han, Y., Granata, R. and Moore, D. D.: Induction of bilirubin clearance by the constitutive androstane receptor CAR. Proc. Natl. Acad. Sci. USA, 100: 4156-4161 2003.
22. Uno, Y., Matsuno, K., Nakamura, C., Utoh, M. and Yamazaki, H.: Cloning, expression, and characterization of CYP3A43 cDNA in cynomolgus macaque Macaca fascicularis. Drug Metab. Lett., 3: 228-233 2009.
23. Bièche, I., Narjoz, C., Asselah, T., Vacher, S., Marcellin, P., Lidereau, R., Beaune, P. and de Waziers, I.: Reverse transcriptase-PCR quantification of mRNA levels from cytochrome CYP.1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet. Genomics, 17: 731-742 2007.
24. Lewin, M. B., Bryant, R. M., Fenrich, A. L. and Grifka, R. G.: Cisapride-induced long QT interval. J. Pediatr., 128: 279-281 1996.
25. van Haarst, A. D., van öt Klooster, G. A., van Gerven, J. M., Schoemaker, R. C., van Oene, J. C., Burggraaf, J., Coene, M. C. and Cohen, A. F.: The influence of cisapride and clarithromycin on QT intervals in healthy volunteers. Clin. Pharmacol. Ther., 64: 542-546 1998.
26. Pearce, R. E., Gotschall, R. R., Kearns, G. L. and Leeder, J. S.: Cytochrome P450 involvement in the biotransformation of cisapride and racemic norcisapride in vitro: differential activity of individual human CYP3A isoforms. Drug Metab. Dispos., 29: 1548-1554 2001.
27. Tréluyer, J. M., Rey, E., Sonnier, M., Pons, G. and Cresteil, T.: Evidence of impaired cisapride metabolism in neonates. Br. J. Clin. Pharmacol., 52: 419-425 2001.
28. Kiefer, J. C.: Epigenetics in development. Dev. Dyn., 236: 1144-1156 2007.
29. Reik, W.: Stability and flexibility of epigenetic gene regulation in mammalian development. Nature, 447: 425-432 2007.
30. Li, Y., Cui, Y., Hart, S. N., Klaassen, C. D. and Zhong, X. B.: Dynamic patterns of histone methylation are associated with ontogenic expression of the Cyp3a genes during mouse liver maturation. Mol. Pharmacol., 75: 1171-1179 2009.
31. Saito, T., Takahashi, Y., Hashimoto, H. and Kamataki, T.: Novel transcriptional regulation of the human CYP3A7 gene by Sp1 and Sp3 through nuclear factor kB-like element. J. Biol. Chem., 276: 38010-38022 2001.
32. Riffel, A. K., Schuenemann, E. and Vyhlidal, C. A.: Regulation of the CYP3A4 and CYP3A7 promoters by members of the nuclear factor I transcription factor family. Mol. Pharmacol., 76: 1104-1114 2009.